MGH 50th Annual Psychopharmacology Conference: Program & Speakers

44 major sessions across 4 days with 60 confirmed speakers — the substantive program for MGH 50th Annual Psychopharmacology Conference, October 16–18, 2026 in Boston, MA. Curated from the official program; excludes posters, exhibits, and social events.

Featured speakers: · · · · · · · · · · · · and 48 more below

Looking for dates, CME credits, pricing, or registration deadlines? They're on the main MGH 50th Annual Psychopharmacology Conference page. For every poster and workshop, see the full official program.

October 15, 2026

  • WorkshopClozapine Workshop

    Hands-on ticketed workshop on initiating, monitoring, and troubleshooting clozapine treatment.

  • WorkshopPharmacology 101 for Psychopharmacologists

    Ticketed workshop reviewing core pharmacokinetic and pharmacodynamic principles underlying psychiatric prescribing.

  • WorkshopThe Role of Cannabis in Medicine

    · · ·

    Ticketed evening session examining the evidence for and against medical cannabis use.

  • WorkshopMedical Issues in Psychiatry

    · ·

    Ticketed evening session on managing medical comorbidity in psychiatric patients.

  • WorkshopObesity and Eating Disorders

    · · · · · ·

    Ticketed evening session covering assessment and treatment of obesity and the spectrum of eating disorders.

  • WorkshopLaw & Psychiatry

    · · ·

    Ticketed evening session on medicolegal issues facing prescribing clinicians.

  • WorkshopNutritional, Lifestyle, and Metabolic Psychiatry

    · · · · ·

    Ticketed evening session on how nutrition, lifestyle change, and metabolic health intersect with psychiatric treatment.

October 16, 2026

  • LectureBipolar Depression

    Current evidence-based pharmacologic management of the depressive phase of bipolar disorder.

  • LectureBipolar Long-Term Management

    Maintenance treatment strategies for keeping bipolar disorder stable over time.

  • LectureTreatment Resistant Depression

    Sequenced strategies for depression that has not responded to standard antidepressant trials.

  • LecturePTSD & Insomnia

    Managing the sleep disruption that accompanies and perpetuates post-traumatic stress disorder.

  • LectureAnxiety Disorders and Treatments

    An update on pharmacologic treatment across the anxiety disorders.

  • LectureCourse and Treatment of Mood/Anxiety During Pregnancy

    How mood and anxiety disorders behave during pregnancy and how to treat them safely.

  • LecturePostpartum Mood and Anxiety Disorders

    Recognition and treatment of depression and anxiety in the postpartum period.

  • SessionPharmacologic Approach to Psychiatric Urgent Care

    Evening seminar on medication strategies for urgent psychiatric presentations.

  • SessionPsychopharmacology of Sleep Disorders

    Evening seminar on medication management of insomnia and other sleep disorders.

  • SessionProdromes, Early Detection and Prevention of Major Psychiatric Illnesses

    Evening seminar on identifying and intervening in the earliest stages of serious mental illness.

  • SessionMental Health and the Benefits of a Healthy Lifestyle

    Evening seminar on lifestyle interventions as adjuncts to psychiatric treatment.

  • SessionStimulation and/or Surgical Approaches to Psychiatric Illness

    Evening seminar on brain stimulation and neurosurgical options for refractory psychiatric illness.

  • SessionPMDD and Depression During Menopausal Transition: New Insights

    ·

    Evening seminar on hormonally influenced mood disorders across the reproductive lifespan.

  • SessionSuicide

    Evening seminar on assessment and management of suicidal patients.

October 17, 2026

  • LectureFirst-Episode Psychosis and Schizophrenia

    Early intervention and pharmacologic management of first-episode psychosis and schizophrenia.

  • LectureManagement of Side-Effects of Antipsychotics

    Preventing and treating the metabolic, motor, and other adverse effects of antipsychotic medications.

  • LectureKetamine and Esketamine: From Research to Clinical Practice

    Translating the ketamine and esketamine evidence base into safe clinical use for depression.

  • LectureNeuromodulation and Interventional Psychiatry

    An overview of TMS, ECT, and other device-based and interventional treatments.

  • LectureNew Treatments for Schizophrenia

    Recently approved and pipeline agents for schizophrenia, including novel mechanisms.

  • LecturePsychedelics

    The current state of psychedelic-assisted therapy research and its clinical implications.

  • LectureAmplifying and Extending Effects of Addiction Treatment

    Strategies for boosting and sustaining recovery outcomes beyond initial addiction treatment.

  • SessionViolence Risk Assessment in Clinical Practice

    ·

    Evening seminar on practical assessment of violence risk in clinical settings.

  • SessionGeriatrics Psychopharmacology

    Evening seminar on prescribing considerations unique to older adults.

  • SessionIlluminating the Black Box: Antidepressants, Youth, and Suicide

    Evening seminar re-examining the evidence behind the antidepressant black-box warning in young people.

  • SessionTraumatic Brain Injury: A Neuropsychiatric Perspective

    Evening seminar on the psychiatric sequelae of TBI and their management.

  • SessionThe Neurobiology of Addiction

    Evening seminar on the brain mechanisms underlying substance use disorders.

  • SessionAdult Autism

    Evening seminar on recognition and care of autism spectrum disorder in adults.

  • SessionPsychopharmacology of Autism

    Evening seminar on medication management of co-occurring symptoms in autism.

  • SessionNatural Medications for Psychiatric Disorders

    Evening seminar on the evidence for supplements and natural products in psychiatry.

October 18, 2026

  • LectureAlcohol and Opioids

    Pharmacotherapy for alcohol and opioid use disorders.

  • LectureTreatment of Tobacco Use Disorders

    Evidence-based approaches to helping patients quit smoking and nicotine use.

  • LecturePsychopharmacology of OCD

    Medication strategies for obsessive-compulsive disorder, including augmentation for partial response.

  • LecturePsychopharmacology for OCD-Related Disorders

    Treating body dysmorphic disorder, tic disorders, and other conditions in the OCD spectrum.

  • LectureCBT, Digital & AI Interventions for OCD & Related Disorders

    How cognitive-behavioral therapy and emerging digital and AI tools are being used to treat OCD-spectrum conditions.

  • LecturePediatric Bipolar Disorder and Mood Disorders

    Diagnosis and treatment of bipolar and other mood disorders in children and adolescents.

  • LectureADHD

    An update on ADHD pharmacotherapy across the lifespan.

  • LectureDrug Interactions

    Clinically important psychotropic drug-drug interactions and how to avoid them.

Program details verified August 20, 2026; sessions and speakers may change — confirm on the official site.

Browse the directory